Lindsay Hample is the Vice President of Global Marketing, Interventional Oncology & Embolization (IO&E) at Boston Scientific Corporation. She provides strategic business leadership for marketing activities and commercial investments with a focus on new product launches, customer engagement, and market development. Lindsay’s primary responsibilities are management of all functions of marketing (upstream, downstream, strategy, therapy development, and brand activation) for the IO&E franchise, part of the Peripheral Interventions division of Boston Scientific. Focused on driving Interventional Oncology growth globally, Lindsay and her team create and deploy innovative marketing tools and programs to drive product adoption and utilization. Lindsay was previously the Director of Global Field Marketing & Patient Access and Director of Global Education and Training within the Urology division. Prior to joining Boston Scientific, Lindsay worked for St. Jude Medical for four years. Her career portfolio includes positions in product management, market development, strategic marketing, medical education, and sales.
Lindsay has also served in leadership roles for employee resource groups and community boards (President of EmPowHer, Executive Sponsor for PRIDE, American Heart Association’s Go Red for Women Executive Leadership Team, MSUM Foundation Board of Directors, and she currently serves on the American Cancer Society Board of Directors for Minnesota). In her spare time, Lindsay enjoys spending time with her family (husband, two sons, and one daughter) and taking in a variety of sporting events.